Skip to main content

Rare Disease Day Quiz graphic

Take the Rare Disease Day Quiz!

Test your knowledge about rare diseases, which affect more people than you think.

23 Feb 2021 Bern Location
CSL Halbjahresergebnisse 2021

CSL Half Year Results 2020-21

CSL Delivers Net Profit of Over $ 1.8 Billion

18 Feb 2021 Company
Scientist and Corona children's book author Sabine Stoffel Domig with her children.

What to Tell the Kids About COVID-19?

A walk to kindergarten with a group of 5-year-olds gave a CSL Behring scientist an idea for a timely children’s book.

10 Feb 2021 Bern Location
coronavirus on a blue background

CSL COVID19 Update

CSL continues to provide medicines to patients around the world.

08 Feb 2021 Company
Vials

What is a Phase III clinical trial?

A potential hyperimmune treatment for COVID-19 reaches a regulatory milestone in testing its efficacy and safety.

06 Nov 2020 Bern Location
COVID Hyperimmune Production

First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine

As co-leader, CSL Behring is very actively involved in this project. The product for the clinical trial phase 3 was manufactu…

09 Oct 2020 Bern Location

Opening of New Manufacturing Facility in Bern

CSL Behring had a small celebration to mark the grand opening of the facility,

08 Oct 2020 Bern Location
Protinus-Batch-Slots

Expansion Nears Completion in Switzerland

CSL Behring validates new production capacity in Bern.

Graphic CSL Full Year Results 2020

CSL Delivers Net Profit of Over $2.1 Billion

CSL Limited (ASX:CSL; USOTC:CSLLY) today announced a reported net profit after tax of $2,103 million (1) for the 12 months en…

19 Aug 2020 Bern Location